{"gene":"SAG","run_date":"2026-04-28T20:42:06","timeline":{"discoveries":[{"year":1987,"finding":"Photoactivated rhodopsin is deactivated by a two-step mechanism: first, rhodopsin kinase phosphorylates light-activated rhodopsin at multiple sites, partially suppressing its ability to activate transducin; second, the 48 kDa S-antigen (arrestin/SAG) binds specifically to the phosphorylated, light-activated rhodopsin and potentiates the inhibitory effect, most likely by competing with transducin for binding to phosphorylated rhodopsin.","method":"Biochemical reconstitution assay measuring transducin-mediated phosphodiesterase activation in rod outer segment preparations; competitive binding experiments","journal":"Journal of receptor research","confidence":"High","confidence_rationale":"Tier 1 — reconstituted in vitro with purified components; foundational mechanism paper replicated across labs","pmids":["3040978"],"is_preprint":false},{"year":1989,"finding":"Arrestin (SAG) specifically inhibits the dephosphorylation of freshly photolyzed (light-activated) phosphorhodopsin by protein phosphatase 2A (PP2A), but does not inhibit dephosphorylation of unbleached rhodopsin nor dephosphorylation of phosphorylase a, indicating substrate-directed protection. This reveals a novel regulatory mechanism by which arrestin binding prevents PP2A access to phosphorhodopsin.","method":"In vitro phosphatase activity assay with purified rod outer segment extracts, okadaic acid inhibition, DEAE-Sepharose chromatography co-elution of opsin phosphatase with PP2A","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro enzymatic assay with rigorous substrate specificity controls; multiple orthogonal biochemical methods","pmids":["2550422"],"is_preprint":false},{"year":1992,"finding":"Reduction of the photolyzed chromophore all-trans-retinal to all-trans-retinol is essential for recycling of photoactivated rhodopsin: once reduction occurs, arrestin dissociates from the receptor and the chromophore site becomes accessible for regeneration. When reduction does not occur, free all-trans-retinal can form a Meta II-like pseudo-photoproduct (M380) that binds arrestin tightly and blocks rhodopsin regeneration.","method":"Spectrophotometric analysis of rhodopsin photoproducts; binding assays of arrestin and rhodopsin kinase to M380 vs native metarhodopsin species; biochemical manipulation of retinal reduction in rod outer segment preparations","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with purified components; multiple functional readouts; mechanistic causality established","pmids":["1386362"],"is_preprint":false},{"year":1999,"finding":"The transition of arrestin from its inactive (basal) conformation to the high-affinity receptor-binding state is triggered by the phosphorylated C-terminal tail of rhodopsin disrupting a hydrogen-bonded network of buried charged residues called the 'polar core' (involving Arg175, Asp30, Asp296, Asp303, Arg382). Mutations that disrupt polar core interactions (e.g., R175E, D296R) bypass the requirement for receptor phosphorylation, enabling arrestin to bind activated, unphosphorylated rhodopsin.","method":"Site-directed mutagenesis of arrestin residues; in vitro binding assays to light-activated phosphorylated and unphosphorylated rhodopsin; second-site suppressor mutagenesis restoring critical interactions; interpreted in conjunction with crystal structure","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — mutagenesis + in vitro functional assay + structural validation; structure-based second-site suppressor mutations confirm the mechanism","pmids":["10206946"],"is_preprint":false},{"year":1999,"finding":"The principal region of arrestin that mediates binding to photoactivated phosphorhodopsin is contained within residues 90–140, with the minimal inhibitory peptide mapping to residues 109–130 (IC50 ~1.1 mM). A GST fusion of residues 95–140 binds rhodopsin regardless of activation or phosphorylation state, indicating this is a primary contact region.","method":"Phage display of arrestin fragments panned against phosphorylated rhodopsin; synthetic peptide competition assay measuring inhibition of arrestin binding and cGMP phosphodiesterase activation; GST fusion protein pulldown","journal":"Biochemistry","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal methods (phage display, peptide competition, fusion protein pulldown); single lab","pmids":["10052946"],"is_preprint":false},{"year":2000,"finding":"Peptide competition assays identified two regions of arrestin (residues 11–30 and 51–70 in the N-terminal domain; residues 231–260 in the C-terminal domain) that interact with metarhodopsin II (MII), with arrestin peptide 11–30 showing selectivity for phosphorylated MII over the transducin-stabilized form. Both the N- and C-terminal domains of arrestin contact rhodopsin, and these sites overlap with transducin-binding surfaces.","method":"Spectrophotometric extra-MII stabilization assay; synthetic peptide competition of arrestin- and transducin-dependent MII stabilization using native disc membranes","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — clean in vitro competition assay with functional readout; single lab but well-controlled","pmids":["10969086"],"is_preprint":false},{"year":2004,"finding":"Arrestin release from rhodopsin and retinal (chromophore) release are directly linked events with similar activation energies. Arrestin slows the rate of retinal release approximately 2-fold at physiological temperatures and abolishes the pH dependence of retinal release. Fluorescence labeling at I72C and S251C reveals these sites are buried at the rhodopsin-arrestin or phospholipid-arrestin interface upon binding. Evidence also indicates arrestin can bind a post-Meta II photodecay product (possibly Meta III).","method":"Fluorescence spectroscopy using monobromobimane-labeled arrestin mutants; kinetic analysis of arrestin and retinal release; EPR and biochemical approaches","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1 — multiple orthogonal methods (fluorescence, EPR, biochemical); defines mechanistic linkage between arrestin and retinal release with activation energy measurements","pmids":["15591052"],"is_preprint":false},{"year":2009,"finding":"Arrestin-1 mutants with enhanced ability to bind active, unphosphorylated rhodopsin (bypassing the need for rhodopsin kinase phosphorylation) partially compensate for defects in rhodopsin phosphorylation in rod photoreceptors in vivo, promoting photoreceptor survival, improving functional ERG responses, and facilitating photoresponse recovery in rhodopsin kinase-deficient mice.","method":"Transgenic mouse model expressing enhanced arrestin-1 mutant in rhodopsin kinase (RK)-deficient rods; electroretinography; photoreceptor cell counting; functional photoresponse recovery measurements","journal":"Current biology : CB","confidence":"High","confidence_rationale":"Tier 2 — in vivo genetic rescue experiment with functional and morphological readouts; demonstrates sufficiency of enhanced arrestin-1 for single-step receptor deactivation","pmids":["19361994"],"is_preprint":false},{"year":2009,"finding":"Arrestin-1 (SAG) is essential for cone photoreceptor survival and light adaptation. In Arr1-knockout mice reared in darkness, viable cone density diminishes over time, and cone ERG b-wave amplitudes fail to increase during light adaptation (3–15 min background illumination), a defect rescued by restoration of Arr1 expression. Either Arr1 or Arr4 is sufficient to maintain normal cone flicker responses.","method":"Arrestin-1 and arrestin-4 knockout mice; quantitative retinal morphology; TUNEL apoptosis assay; immunohistochemistry; electroretinography (ERG) light adaptation and flicker protocols; transgenic rescue","journal":"Investigative ophthalmology & visual science","confidence":"High","confidence_rationale":"Tier 2 — multiple knockout genotypes with functional ERG and morphological readouts; transgenic rescue confirms specificity","pmids":["20019357"],"is_preprint":false},{"year":2012,"finding":"Upon binding to light-activated phosphorylated rhodopsin (P-Rh*), the 'finger loop' (residues 67–79) of arrestin-1 moves toward the expected location of P-Rh*, but does not adopt a fully extended conformation. A striking movement of the loop containing residue 139 away from the adjacent finger loop facilitates receptor binding. The relative position of the N and C domains remains largely unchanged (contra the 'clam-shell' model). Loops at residues 139, 157, and 344 show high flexibility in both free and receptor-bound arrestin-1.","method":"Double electron-electron resonance (DEER) EPR spectroscopy with spin-labeled arrestin-1 pairs; distance measurements in free vs. P-Rh*-bound arrestin-1","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — DEER/EPR distance measurements provide direct structural information on receptor-bound conformation; multiple spin-label pairs","pmids":["23091036"],"is_preprint":false},{"year":2013,"finding":"The crystal structure of bovine arrestin-1 splice variant p44 (C-tail truncation mimicking activation) at 3.0 Å reveals the pre-activated arrestin conformation: breakage of the polar core and other interlobe hydrogen-bond networks leads to ~21° rotation of the two lobes. Key receptor-binding loops in the central crest region (finger loop, loop 139, gate loop Asp296–Asn305) rearrange from restricted to extended conformations. C-tail displacement releases these loops and enables receptor binding, confirmed by site-directed fluorescence spectroscopy.","method":"X-ray crystallography at 3.0 Å; site-directed fluorescence spectroscopy validating conformational changes; comparison with basal arrestin-1 structure","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 — crystal structure plus functional fluorescence validation; high-impact journal; provides structural mechanism of activation","pmids":["23604253"],"is_preprint":false},{"year":2016,"finding":"Scanning mutagenesis of all arrestin-1 residues reveals that binding to phosphorylated agonist-bound rhodopsin (Meta II-P) and phosphorylated apo-receptor (Ops-P) both require arrestin activation (polar core disruption or C-tail displacement), but the two complexes are structurally distinct: phosphate-binding residues (phosphosensors), inter-domain interface residues, receptor-binding loops, and C-edge residues contribute differently to the two receptor forms, indicating different binding modes.","method":"Unbiased scanning mutagenesis of all arrestin residues; in vitro binding assays to Meta II-P and Ops-P; quantitative comparison of mutant effects across both receptor forms","journal":"Scientific reports","confidence":"High","confidence_rationale":"Tier 1 — comprehensive mutagenesis across entire protein with two distinct receptor state readouts; systematic and well-controlled","pmids":["27350090"],"is_preprint":false},{"year":2017,"finding":"Molecular dynamics simulations and site-directed fluorescence spectroscopy demonstrate that C-edge loops of arrestin-1 function as a membrane anchor during rhodopsin interaction. Activation of arrestin by receptor-attached phosphates is necessary for C-edge engagement of the membrane. The C-edge conformation and orientation differ between the pre-complex (arrestin interacting with phosphorylated receptor C-terminus only) and the high-affinity complex.","method":"Molecular dynamics simulations; site-directed fluorescence spectroscopy experiments on arrestin-1 interactions with rhodopsin in membranes","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1 — MD simulations validated by site-directed fluorescence spectroscopy; mechanistically defines membrane anchoring role of C-edge","pmids":["28220785"],"is_preprint":false},{"year":2020,"finding":"Comprehensive mutagenesis of the finger loop in bovine visual arrestin-1 demonstrates that the finger loop is the key element of the activation sensor: the majority of finger loop residues are important for binding to light-activated rhodopsin, with six mutations affecting binding exclusively to the light-activated form (not phosphorylated dark rhodopsin or unphosphorylated active rhodopsin). This establishes the finger loop as the structural element that detects the active conformation of the receptor.","method":"Comprehensive site-directed mutagenesis of finger loop residues in arrestin-1; cell-free translation of radiolabeled mutant proteins; in vitro binding assays to multiple rhodopsin functional forms (P-Rh*, Rh*, P-Rh, Rh); tested in both WT and C-terminally truncated arrestin-1 backgrounds","journal":"Journal of neurochemistry","confidence":"High","confidence_rationale":"Tier 1 — comprehensive mutagenesis across full finger loop with multiple receptor state readouts; systematic and internally controlled","pmids":["33159335"],"is_preprint":false},{"year":2021,"finding":"Inositol phosphates (InsPs) bind to the N-domain basic patch of visual arrestin-1 (Arr1), displacing the C-tail, suggesting they prime Arr1 for rhodopsin interaction and may direct Arr1 translocation from inner to outer photoreceptor segments. Crystal structures show that C-tail removal by InsP binding leaves the polar core intact, indicating InsP binding is insufficient to fully activate Arr1 but acts as a priming step.","method":"X-ray crystallography of bovine Arr1 in ligand-free state (near-complete C-tail model) and InsP-bound states; structural comparison","journal":"Structure (London, England : 1993)","confidence":"High","confidence_rationale":"Tier 1 — crystal structure with near-complete C-tail model; mechanistic interpretation of InsP binding and priming supported by structural data","pmids":["34678158"],"is_preprint":false}],"current_model":"SAG (visual/rod arrestin, arrestin-1) terminates phototransduction by binding specifically to light-activated, rhodopsin kinase-phosphorylated rhodopsin: phosphorylated receptor C-tail contacts the arrestin N-domain basic patch and phosphosensors, disrupting a buried polar core (Arg175, Asp30, Asp296, Asp303, Arg382) and releasing the C-tail, which triggers an ~21° inter-domain rotation, extension of the finger loop and loop-139 into the receptor cavity, and engagement of C-edge loops as a membrane anchor; once bound, arrestin sterically blocks transducin coupling, inhibits PP2A-mediated dephosphorylation of phosphorhodopsin, slows retinal chromophore release (linking arrestin dissociation to retinal reduction), and is essential in vivo for cone photoreceptor survival and light adaptation, while inositol phosphates can prime arrestin for receptor binding by displacing its C-tail without fully activating it."},"narrative":{"teleology":[{"year":1987,"claim":"Established that rhodopsin shut-off requires two sequential steps — phosphorylation by rhodopsin kinase followed by SAG binding — resolving how transducin activation is quenched after photon absorption.","evidence":"Biochemical reconstitution measuring transducin-stimulated PDE activity in rod outer segments with purified components","pmids":["3040978"],"confidence":"High","gaps":["Stoichiometry of phosphorylation sites required for arrestin binding was undefined","Mechanism of arrestin selectivity for phosphorylated vs. unphosphorylated receptor was unknown"]},{"year":1989,"claim":"Revealed a second regulatory function of arrestin — shielding phosphorhodopsin from PP2A-mediated dephosphorylation — explaining how the deactivated state is maintained until the receptor is recycled.","evidence":"In vitro phosphatase assays with purified rod outer segment extracts and substrate specificity controls","pmids":["2550422"],"confidence":"High","gaps":["Identity of the in vivo opsin phosphatase was not settled","Whether arrestin shielding is relieved by retinal release was untested"]},{"year":1992,"claim":"Linked arrestin dissociation from rhodopsin to all-trans-retinal reduction, establishing that visual-cycle chromophore recycling cannot proceed while arrestin remains bound.","evidence":"Spectrophotometric analysis of rhodopsin photoproducts and arrestin binding to M380 pseudo-photoproduct","pmids":["1386362"],"confidence":"High","gaps":["Kinetic coupling between retinal reduction and arrestin release was not quantified at physiological temperature","Enzyme identity for retinal reduction in situ was not addressed"]},{"year":1999,"claim":"Identified the polar core (Arg175, Asp30, Asp296, Asp303, Arg382) as the phosphosensor whose disruption switches arrestin from the basal to the receptor-binding conformation, answering how arrestin discriminates phosphorylated from unphosphorylated receptor.","evidence":"Site-directed and second-site suppressor mutagenesis with in vitro rhodopsin binding assays, interpreted alongside the crystal structure","pmids":["10206946"],"confidence":"High","gaps":["Full structural view of the activated state was lacking","Which phosphorylation sites on rhodopsin contact the polar core was unresolved"]},{"year":1999,"claim":"Mapped the primary rhodopsin-contact surface of arrestin to residues 90–140, narrowing the receptor-binding interface and highlighting the finger-loop region.","evidence":"Phage display, synthetic peptide competition of arrestin binding, and GST-fusion pulldowns","pmids":["10052946"],"confidence":"Medium","gaps":["Peptide-based mapping cannot capture conformational contributions","Residue-level resolution within the 90–140 segment was not achieved"]},{"year":2004,"claim":"Quantified that arrestin slows retinal release ~2-fold and that arrestin and retinal dissociation share similar activation energies, mechanistically coupling receptor desensitization to chromophore recycling kinetics.","evidence":"Fluorescence spectroscopy with monobromobimane-labeled arrestin mutants; kinetic and thermodynamic analysis","pmids":["15591052"],"confidence":"High","gaps":["Whether the coupling is direct or mediated by conformational intermediates was unresolved","In vivo relevance of the ~2-fold slowing was not tested"]},{"year":2009,"claim":"Demonstrated in vivo that SAG is essential for cone survival and light adaptation, and that enhanced-binding arrestin-1 mutants can partly rescue rhodopsin kinase deficiency, establishing the physiological sufficiency of arrestin for single-step receptor shut-off.","evidence":"Arrestin-1 and arrestin-4 knockout mice; transgenic rescue; ERG light-adaptation and flicker protocols; photoreceptor morphometry","pmids":["20019357","19361994"],"confidence":"High","gaps":["Mechanism by which SAG promotes cone survival independent of rod desensitization was unclear","Whether enhanced mutants cause long-term toxicity in vivo was not assessed"]},{"year":2012,"claim":"DEER/EPR distance measurements on receptor-bound arrestin-1 showed that the finger loop and loop-139 move toward the receptor upon binding but the inter-domain arrangement is more subtle than a simple clam-shell opening, revising the structural model of arrestin activation.","evidence":"Double electron-electron resonance (DEER) EPR with multiple spin-label pairs on arrestin-1 free and bound to P-Rh*","pmids":["23091036"],"confidence":"High","gaps":["Full atomic-resolution model of the rhodopsin–arrestin complex was still missing","Contribution of membrane lipids to the bound-state conformation was not addressed"]},{"year":2013,"claim":"Crystal structure of the pre-activated arrestin-1 (p44 splice variant) at 3.0 Å revealed the ~21° inter-domain rotation, polar-core breakage, and central-crest loop rearrangements triggered by C-tail displacement, providing the first high-resolution view of the activated arrestin conformation.","evidence":"X-ray crystallography of arrestin-1 p44; site-directed fluorescence spectroscopy validation","pmids":["23604253"],"confidence":"High","gaps":["Structure was of a C-tail-truncated variant, not of the full-length receptor-bound complex","Dynamics of the transition from basal to activated state were not captured"]},{"year":2016,"claim":"Comprehensive scanning mutagenesis showed that arrestin-1 engages phosphorylated agonist-bound (Meta II-P) and phosphorylated apo-receptor (Ops-P) rhodopsin through structurally distinct binding modes, with different contributions of phosphosensors, inter-domain interface, and C-edge loops.","evidence":"Systematic mutagenesis of all arrestin residues; quantitative in vitro binding to Meta II-P vs. Ops-P","pmids":["27350090"],"confidence":"High","gaps":["Structural basis of the distinct binding modes at atomic resolution was not available","Physiological significance of the Ops-P complex in dark adaptation was unclear"]},{"year":2017,"claim":"Identified C-edge loops as a phosphorylation-dependent membrane anchor that adopts different orientations in the pre-complex versus the high-affinity complex, adding a lipid-engagement step to the arrestin activation model.","evidence":"Molecular dynamics simulations validated by site-directed fluorescence spectroscopy of arrestin-1 on rhodopsin-containing membranes","pmids":["28220785"],"confidence":"High","gaps":["Lipid specificity of C-edge engagement was not defined","Whether C-edge membrane anchoring is required in vivo was untested"]},{"year":2020,"claim":"Comprehensive finger-loop mutagenesis established this element as the primary activation sensor of arrestin-1, with six residues selectively required for binding only to the light-activated receptor form, separating the activation-sensing and phosphosensing functions of arrestin.","evidence":"Site-directed mutagenesis of all finger-loop residues; binding assays to four distinct rhodopsin functional forms in WT and C-tail-truncated backgrounds","pmids":["33159335"],"confidence":"High","gaps":["Whether these residues insert into the receptor transmembrane core was structurally unconfirmed for visual arrestin","Energetic contribution of individual finger-loop contacts was not measured"]},{"year":2021,"claim":"Crystal structures of arrestin-1 with inositol phosphates showed that InsPs displace the C-tail by binding the N-domain basic patch but leave the polar core intact, defining a priming mechanism distinct from full activation and potentially regulating arrestin translocation in photoreceptors.","evidence":"X-ray crystallography of bovine Arr1 ligand-free (with near-complete C-tail) and InsP-bound states","pmids":["34678158"],"confidence":"High","gaps":["In vivo role of InsP-mediated priming in arrestin translocation is undemonstrated","Whether InsP priming synergizes with partial receptor phosphorylation was untested"]},{"year":null,"claim":"A high-resolution structure of full-length mammalian arrestin-1 bound to native phosphorylated rhodopsin in a lipid bilayer, capturing the complete binding interface including C-edge membrane contacts, remains to be determined.","evidence":"","pmids":[],"confidence":"High","gaps":["No cryo-EM or crystal structure of the full-length mammalian Arr1–P-Rh* complex in a membrane environment","Kinetic pathway of arrestin activation (order of polar-core disruption, C-tail release, finger-loop insertion, membrane anchoring) is not resolved in real time","In vivo role of InsP-mediated priming in photoreceptor arrestin translocation lacks direct evidence"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,1,7,8]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[0,3,11]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[12]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[14]}],"pathway":[{"term_id":"R-HSA-9709957","term_label":"Sensory Perception","supporting_discovery_ids":[0,2,7,8]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,3,7,8]}],"complexes":["Rhodopsin–arrestin-1 complex"],"partners":["RHO","GRK1","PPP2CA","SAG"],"other_free_text":[]},"mechanistic_narrative":"SAG (S-arrestin/arrestin-1) is the principal terminator of rod phototransduction, binding light-activated, rhodopsin kinase–phosphorylated rhodopsin to sterically block transducin coupling and shield the receptor from PP2A-mediated dephosphorylation [PMID:3040978, PMID:2550422]. Phosphorylated rhodopsin's C-tail disrupts arrestin's buried polar core (Arg175–Asp30–Asp296–Asp303–Arg382), releasing the autoinhibitory C-tail and triggering an ~21° inter-domain rotation that extends the finger loop and loop-139 into the receptor cavity while C-edge loops anchor to the membrane [PMID:10206946, PMID:23604253, PMID:28220785, PMID:33159335]. Arrestin binding slows retinal chromophore release from rhodopsin, coupling arrestin dissociation to all-trans-retinal reduction and visual-cycle recycling [PMID:1386362, PMID:15591052]. In vivo, SAG is essential for cone photoreceptor survival and light adaptation, and enhanced-binding arrestin-1 mutants can partially rescue rhodopsin kinase deficiency [PMID:20019357, PMID:19361994]."},"prefetch_data":{"uniprot":{"accession":"P10523","full_name":"S-arrestin","aliases":["48 kDa protein","Retinal S-antigen","S-AG","Rod photoreceptor arrestin"],"length_aa":405,"mass_kda":45.1,"function":"Binds to photoactivated, phosphorylated RHO and terminates RHO signaling via G-proteins by competing with G-proteins for the same binding site on RHO (By similarity). May play a role in preventing light-dependent degeneration of retinal photoreceptor cells (PubMed:9565049)","subcellular_location":"Cell projection, cilium, photoreceptor outer segment; Membrane","url":"https://www.uniprot.org/uniprotkb/P10523/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/SAG","classification":"Not Classified","n_dependent_lines":2,"n_total_lines":1208,"dependency_fraction":0.0016556291390728477},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/SAG","total_profiled":1310},"omim":[{"mim_id":"620880","title":"AUTOINFLAMMATION WITH ARTHRITIS AND VASCULITIS; AIARV","url":"https://www.omim.org/entry/620880"},{"mim_id":"620228","title":"RETINITIS PIGMENTOSA 96; RP96","url":"https://www.omim.org/entry/620228"},{"mim_id":"619788","title":"ARRESTIN DOMAIN-CONTAINING PROTEIN 4; ARRDC4","url":"https://www.omim.org/entry/619788"},{"mim_id":"617728","title":"CENTROSOMAL PROTEIN, 295-KD; CEP295","url":"https://www.omim.org/entry/617728"},{"mim_id":"617700","title":"UBIQUITIN-CONJUGATING ENZYME E2 F; UBE2F","url":"https://www.omim.org/entry/617700"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"retina","ntpm":1359.9}],"url":"https://www.proteinatlas.org/search/SAG"},"hgnc":{"alias_symbol":["ARRESTIN","RP47"],"prev_symbol":[]},"alphafold":{"accession":"P10523","domains":[{"cath_id":"2.60.40.840","chopping":"15-184_365-382","consensus_level":"high","plddt":85.7331,"start":15,"end":382},{"cath_id":"2.60.40.640","chopping":"194-361","consensus_level":"high","plddt":91.9445,"start":194,"end":361}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P10523","model_url":"https://alphafold.ebi.ac.uk/files/AF-P10523-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P10523-F1-predicted_aligned_error_v6.png","plddt_mean":85.06},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=SAG","jax_strain_url":"https://www.jax.org/strain/search?query=SAG"},"sequence":{"accession":"P10523","fasta_url":"https://rest.uniprot.org/uniprotkb/P10523.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P10523/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P10523"}},"corpus_meta":[{"pmid":"2163110","id":"PMC_2163110","title":"beta-Arrestin: a protein that regulates beta-adrenergic receptor function.","date":"1990","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/2163110","citation_count":1024,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21680031","id":"PMC_21680031","title":"β-Arrestin-mediated receptor trafficking and signal transduction.","date":"2011","source":"Trends in pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/21680031","citation_count":587,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1517224","id":"PMC_1517224","title":"Beta-arrestin2, a novel member of the arrestin/beta-arrestin gene family.","date":"1992","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/1517224","citation_count":433,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20427692","id":"PMC_20427692","title":"Beyond desensitization: physiological relevance of arrestin-dependent signaling.","date":"2010","source":"Pharmacological reviews","url":"https://pubmed.ncbi.nlm.nih.gov/20427692","citation_count":300,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15102497","id":"PMC_15102497","title":"The molecular acrobatics of arrestin activation.","date":"2004","source":"Trends in pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/15102497","citation_count":276,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18787115","id":"PMC_18787115","title":"Beta-blockers alprenolol and carvedilol stimulate beta-arrestin-mediated EGFR transactivation.","date":"2008","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/18787115","citation_count":233,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18086673","id":"PMC_18086673","title":"beta-arrestin-biased agonism at the beta2-adrenergic receptor.","date":"2007","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18086673","citation_count":219,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17215450","id":"PMC_17215450","title":"Beta-arrestin signaling and regulation of transcription.","date":"2007","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/17215450","citation_count":214,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18664266","id":"PMC_18664266","title":"On the origins of arrestin and rhodopsin.","date":"2008","source":"BMC evolutionary biology","url":"https://pubmed.ncbi.nlm.nih.gov/18664266","citation_count":194,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29720660","id":"PMC_29720660","title":"Catalytic activation of β-arrestin by GPCRs.","date":"2018","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/29720660","citation_count":167,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29720655","id":"PMC_29720655","title":"Molecular mechanism of GPCR-mediated arrestin activation.","date":"2018","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/29720655","citation_count":167,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16267056","id":"PMC_16267056","title":"Seven-transmembrane receptor signaling through beta-arrestin.","date":"2005","source":"Science's STKE : signal transduction knowledge environment","url":"https://pubmed.ncbi.nlm.nih.gov/16267056","citation_count":153,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10206946","id":"PMC_10206946","title":"How does arrestin respond to the phosphorylated state of rhodopsin?","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10206946","citation_count":153,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19001375","id":"PMC_19001375","title":"How does arrestin assemble MAPKs into a signaling complex?","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19001375","citation_count":144,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15001578","id":"PMC_15001578","title":"Differential beta-arrestin trafficking and endosomal sorting of somatostatin receptor subtypes.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15001578","citation_count":143,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8340388","id":"PMC_8340388","title":"Polypeptide variants of beta-arrestin and arrestin3.","date":"1993","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8340388","citation_count":137,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8308033","id":"PMC_8308033","title":"Cone arrestin identified by targeting expression of a functional family.","date":"1994","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/8308033","citation_count":135,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23604253","id":"PMC_23604253","title":"Crystal structure of pre-activated arrestin p44.","date":"2013","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/23604253","citation_count":134,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27827372","id":"PMC_27827372","title":"Functional competence of a partially engaged GPCR-β-arrestin complex.","date":"2016","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/27827372","citation_count":131,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1386362","id":"PMC_1386362","title":"The role of arrestin and retinoids in the regeneration pathway of rhodopsin.","date":"1992","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/1386362","citation_count":130,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33296703","id":"PMC_33296703","title":"How GPCR Phosphorylation Patterns Orchestrate Arrestin-Mediated Signaling.","date":"2020","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33296703","citation_count":126,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"2550422","id":"PMC_2550422","title":"Regulation of rhodopsin dephosphorylation by arrestin.","date":"1989","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/2550422","citation_count":120,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26471844","id":"PMC_26471844","title":"Emerging Functional Divergence of β-Arrestin Isoforms in GPCR Function.","date":"2015","source":"Trends in endocrinology and metabolism: TEM","url":"https://pubmed.ncbi.nlm.nih.gov/26471844","citation_count":116,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15780588","id":"PMC_15780588","title":"Arrestin times for compartmentalised cAMP signalling and phosphodiesterase-4 enzymes.","date":"2005","source":"Current opinion in cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/15780588","citation_count":109,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10212203","id":"PMC_10212203","title":"Regulation of muscarinic acetylcholine receptor sequestration and function by beta-arrestin.","date":"1999","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10212203","citation_count":107,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29127291","id":"PMC_29127291","title":"Structural basis of arrestin-3 activation and signaling.","date":"2017","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/29127291","citation_count":105,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8224247","id":"PMC_8224247","title":"X-arrestin: a new retinal arrestin mapping to the X chromosome.","date":"1993","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/8224247","citation_count":100,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"3040978","id":"PMC_3040978","title":"Deactivation of photoactivated rhodopsin by rhodopsin-kinase and arrestin.","date":"1987","source":"Journal of receptor research","url":"https://pubmed.ncbi.nlm.nih.gov/3040978","citation_count":97,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11160859","id":"PMC_11160859","title":"Beta-arrestin- and dynamin-dependent endocytosis of the AT1 angiotensin receptor.","date":"2001","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/11160859","citation_count":95,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20189994","id":"PMC_20189994","title":"Morphine-like opiates selectively antagonize receptor-arrestin interactions.","date":"2010","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/20189994","citation_count":90,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12962621","id":"PMC_12962621","title":"The new face of active receptor bound arrestin attracts new partners.","date":"2003","source":"Structure (London, England : 1993)","url":"https://pubmed.ncbi.nlm.nih.gov/12962621","citation_count":88,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29872229","id":"PMC_29872229","title":"Molecular mechanism of modulating arrestin conformation by GPCR phosphorylation.","date":"2018","source":"Nature structural & molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/29872229","citation_count":87,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23091036","id":"PMC_23091036","title":"Conformation of receptor-bound visual arrestin.","date":"2012","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/23091036","citation_count":84,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28220785","id":"PMC_28220785","title":"C-edge loops of arrestin function as a membrane anchor.","date":"2017","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/28220785","citation_count":84,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24430184","id":"PMC_24430184","title":"Inactivation of SAG/RBX2 E3 ubiquitin ligase suppresses KrasG12D-driven lung tumorigenesis.","date":"2014","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/24430184","citation_count":81,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"18276584","id":"PMC_18276584","title":"Beta-arrestin-mediated signaling regulates protein synthesis.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18276584","citation_count":80,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23136067","id":"PMC_23136067","title":"Functional characterization of SAG/RBX2/ROC2/RNF7, an antioxidant protein and an E3 ubiquitin ligase.","date":"2012","source":"Protein & cell","url":"https://pubmed.ncbi.nlm.nih.gov/23136067","citation_count":80,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"14769794","id":"PMC_14769794","title":"Alternative, nonapoptotic programmed cell death: mediation by arrestin 2, ERK2, and Nur77.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14769794","citation_count":78,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11483657","id":"PMC_11483657","title":"Agonist-induced internalization of the metabotropic glutamate receptor 1a is arrestin- and dynamin-dependent.","date":"2001","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11483657","citation_count":76,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29636212","id":"PMC_29636212","title":"Structural Basis of Arrestin-Dependent Signal Transduction.","date":"2018","source":"Trends in biochemical sciences","url":"https://pubmed.ncbi.nlm.nih.gov/29636212","citation_count":68,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15591052","id":"PMC_15591052","title":"Dynamics of arrestin-rhodopsin interactions: arrestin and retinal release are directly linked events.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15591052","citation_count":67,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10969086","id":"PMC_10969086","title":"Interactions of metarhodopsin II. Arrestin peptides compete with arrestin and transducin.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10969086","citation_count":67,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19361994","id":"PMC_19361994","title":"Enhanced arrestin facilitates recovery and protects rods lacking rhodopsin phosphorylation.","date":"2009","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/19361994","citation_count":67,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37146613","id":"PMC_37146613","title":"Plasma membrane preassociation drives β-arrestin coupling to receptors and activation.","date":"2023","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/37146613","citation_count":62,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33557162","id":"PMC_33557162","title":"Receptor-Arrestin Interactions: The GPCR Perspective.","date":"2021","source":"Biomolecules","url":"https://pubmed.ncbi.nlm.nih.gov/33557162","citation_count":61,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28558341","id":"PMC_28558341","title":"Understanding the GPCR biased signaling through G protein and arrestin complex structures.","date":"2017","source":"Current opinion in structural biology","url":"https://pubmed.ncbi.nlm.nih.gov/28558341","citation_count":60,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24292823","id":"PMC_24292823","title":"Arrestin interactions with G protein-coupled receptors.","date":"2014","source":"Handbook of experimental pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/24292823","citation_count":60,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11041847","id":"PMC_11041847","title":"Arrestin isoforms dictate differential kinetics of A2B adenosine receptor trafficking.","date":"2000","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11041847","citation_count":58,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28600951","id":"PMC_28600951","title":"Structural mechanism of arrestin activation.","date":"2017","source":"Current opinion in structural biology","url":"https://pubmed.ncbi.nlm.nih.gov/28600951","citation_count":56,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23764050","id":"PMC_23764050","title":"Structural determinants of arrestin functions.","date":"2013","source":"Progress in molecular biology and translational science","url":"https://pubmed.ncbi.nlm.nih.gov/23764050","citation_count":54,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30120413","id":"PMC_30120413","title":"Arrestin recruitment to dopamine D2 receptor mediates locomotion but not incentive motivation.","date":"2018","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/30120413","citation_count":54,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11877451","id":"PMC_11877451","title":"Regulation of arrestin-3 phosphorylation by casein kinase II.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11877451","citation_count":52,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19597700","id":"PMC_19597700","title":"Diversity in arrestin function.","date":"2009","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/19597700","citation_count":51,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37558880","id":"PMC_37558880","title":"Tail engagement of arrestin at the glucagon receptor.","date":"2023","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/37558880","citation_count":48,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37844230","id":"PMC_37844230","title":"Signal transduction at GPCRs: Allosteric activation of the ERK MAPK by β-arrestin.","date":"2023","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/37844230","citation_count":45,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31127272","id":"PMC_31127272","title":"Arrestin-β-1 Physically Scaffolds TSH and IGF1 Receptors to Enable Crosstalk.","date":"2019","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/31127272","citation_count":45,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8475065","id":"PMC_8475065","title":"Beta-arrestin and arrestin are recognized by autoantibodies in sera from multiple sclerosis patients.","date":"1993","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/8475065","citation_count":45,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32888497","id":"PMC_32888497","title":"SnapShot: β-Arrestin Functions.","date":"2020","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/32888497","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28855087","id":"PMC_28855087","title":"FPR2 signaling without β-arrestin recruitment alters the functional repertoire of neutrophils.","date":"2017","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/28855087","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25446289","id":"PMC_25446289","title":"Overview of different mechanisms of arrestin-mediated signaling.","date":"2014","source":"Current protocols in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/25446289","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32632293","id":"PMC_32632293","title":"Allosteric interactions in the parathyroid hormone GPCR-arrestin complex formation.","date":"2020","source":"Nature chemical biology","url":"https://pubmed.ncbi.nlm.nih.gov/32632293","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23764049","id":"PMC_23764049","title":"True arrestins and arrestin-fold proteins: a structure-based appraisal.","date":"2013","source":"Progress in molecular biology and translational science","url":"https://pubmed.ncbi.nlm.nih.gov/23764049","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30894814","id":"PMC_30894814","title":"Therapeutic Potential of Targeting ß-Arrestin.","date":"2019","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/30894814","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24907413","id":"PMC_24907413","title":"Role for β-arrestin in mediating paradoxical β2AR and PAR2 signaling in asthma.","date":"2014","source":"Current opinion in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/24907413","citation_count":40,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1544376","id":"PMC_1544376","title":"Cloning and expression of SAG: a novel marker of cellular senescence.","date":"1992","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/1544376","citation_count":39,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23891976","id":"PMC_23891976","title":"Progastrin stimulates colonic cell proliferation via CCK2R- and β-arrestin-dependent suppression of BMP2.","date":"2013","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/23891976","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16325568","id":"PMC_16325568","title":"Beta-arrestin goes nuclear.","date":"2005","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/16325568","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32929862","id":"PMC_32929862","title":"Exploring GPCR-arrestin interfaces with genetically encoded crosslinkers.","date":"2020","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/32929862","citation_count":36,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20100567","id":"PMC_20100567","title":"Transduced Tat-SAG fusion protein protects against oxidative stress and brain ischemic insult.","date":"2010","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/20100567","citation_count":36,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28174117","id":"PMC_28174117","title":"β-arrestin signalling and bias in hormone-responsive GPCRs.","date":"2017","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/28174117","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30703488","id":"PMC_30703488","title":"The structural basis of the arrestin binding to GPCRs.","date":"2019","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/30703488","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26921391","id":"PMC_26921391","title":"β-Arrestin-2 Counters CXCR7-Mediated EGFR Transactivation and Proliferation.","date":"2016","source":"Molecular cancer research : MCR","url":"https://pubmed.ncbi.nlm.nih.gov/26921391","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33799570","id":"PMC_33799570","title":"Differential Involvement of ACKR3 C-Tail in β-Arrestin Recruitment, Trafficking and Internalization.","date":"2021","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/33799570","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22610101","id":"PMC_22610101","title":"Arrestin scaffolds NHERF1 to the P2Y12 receptor to regulate receptor internalization.","date":"2012","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22610101","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25016018","id":"PMC_25016018","title":"Differential regulation of endosomal GPCR/β-arrestin complexes and trafficking by MAPK.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/25016018","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31849219","id":"PMC_31849219","title":"β-Arrestin-2 BRET Biosensors Detect Different β-Arrestin-2 Conformations in Interaction with GPCRs.","date":"2019","source":"ACS sensors","url":"https://pubmed.ncbi.nlm.nih.gov/31849219","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24786833","id":"PMC_24786833","title":"Ubiquitination by SAG regulates macrophage survival/death and immune response during infection.","date":"2014","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/24786833","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27543965","id":"PMC_27543965","title":"SAG/Rbx2-Dependent Neddylation Regulates T-Cell Responses.","date":"2016","source":"The American journal of pathology","url":"https://pubmed.ncbi.nlm.nih.gov/27543965","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20019357","id":"PMC_20019357","title":"Visual Arrestin 1 contributes to cone photoreceptor survival and light adaptation.","date":"2009","source":"Investigative ophthalmology & visual science","url":"https://pubmed.ncbi.nlm.nih.gov/20019357","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17949685","id":"PMC_17949685","title":"Rod1, an arrestin-related protein, is phosphorylated by Snf1-kinase in Saccharomyces cerevisiae.","date":"2007","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/17949685","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32145688","id":"PMC_32145688","title":"Gossypol inhibits cullin neddylation by targeting SAG-CUL5 and RBX1-CUL1 complexes.","date":"2020","source":"Neoplasia (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/32145688","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27350090","id":"PMC_27350090","title":"Functional map of arrestin binding to phosphorylated opsin, with and without agonist.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27350090","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34465145","id":"PMC_34465145","title":"The α-Arrestin ARRDC3 Is an Emerging Multifunctional Adaptor Protein in Cancer.","date":"2022","source":"Antioxidants & redox signaling","url":"https://pubmed.ncbi.nlm.nih.gov/34465145","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24292833","id":"PMC_24292833","title":"Arrestin-dependent activation of ERK and Src family kinases.","date":"2014","source":"Handbook of experimental pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/24292833","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31399503","id":"PMC_31399503","title":"Calcium-Sensing Receptor Internalization Is β-Arrestin-Dependent and Modulated by Allosteric Ligands.","date":"2019","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/31399503","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25446290","id":"PMC_25446290","title":"Arrestin expression in E. coli and purification.","date":"2014","source":"Current protocols in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/25446290","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23360390","id":"PMC_23360390","title":"Phosphorylation regulates TRPV1 association with β-arrestin-2.","date":"2013","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/23360390","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"31659746","id":"PMC_31659746","title":"Arrestin-independent constitutive endocytosis of GPR125/ADGRA3.","date":"2019","source":"Annals of the New York Academy of Sciences","url":"https://pubmed.ncbi.nlm.nih.gov/31659746","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38906769","id":"PMC_38906769","title":"GPCR-dependent and -independent arrestin signaling.","date":"2024","source":"Trends in pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/38906769","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34740971","id":"PMC_34740971","title":"Activation of PTH1R alleviates epididymitis and orchitis through Gq and β-arrestin-1 pathways.","date":"2021","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/34740971","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9931451","id":"PMC_9931451","title":"Isolation and characterization of the human X-arrestin gene.","date":"1998","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/9931451","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33159335","id":"PMC_33159335","title":"The finger loop as an activation sensor in arrestin.","date":"2020","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/33159335","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25425623","id":"PMC_25425623","title":"Engineered hyperphosphorylation of the β2-adrenoceptor prolongs arrestin-3 binding and induces arrestin internalization.","date":"2014","source":"Molecular pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/25425623","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26825061","id":"PMC_26825061","title":"Structural mechanism of GPCR-arrestin interaction: recent breakthroughs.","date":"2016","source":"Archives of pharmacal research","url":"https://pubmed.ncbi.nlm.nih.gov/26825061","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34678158","id":"PMC_34678158","title":"Structural evidence for visual arrestin priming via complexation of phosphoinositols.","date":"2021","source":"Structure (London, England : 1993)","url":"https://pubmed.ncbi.nlm.nih.gov/34678158","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25484000","id":"PMC_25484000","title":"Molecular mechanism of phosphorylation-dependent arrestin activation.","date":"2014","source":"Current opinion in structural biology","url":"https://pubmed.ncbi.nlm.nih.gov/25484000","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26582201","id":"PMC_26582201","title":"β-Arrestin 2 Promotes Hepatocyte Apoptosis by Inhibiting Akt Protein.","date":"2015","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/26582201","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10052946","id":"PMC_10052946","title":"Identification of regions of arrestin that bind to rhodopsin.","date":"1999","source":"Biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10052946","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35427647","id":"PMC_35427647","title":"Selective phosphorylation of threonine residues defines GPR84-arrestin interactions of biased ligands.","date":"2022","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/35427647","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32803684","id":"PMC_32803684","title":"Many faces of the GPCR-arrestin interaction.","date":"2020","source":"Archives of pharmacal research","url":"https://pubmed.ncbi.nlm.nih.gov/32803684","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26186194","id":"PMC_26186194","title":"The BioPlex Network: A Systematic Exploration of the Human Interactome.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26186194","citation_count":1118,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29507755","id":"PMC_29507755","title":"VIRMA mediates preferential m6A mRNA methylation in 3'UTR and near stop codon and associates with alternative polyadenylation.","date":"2018","source":"Cell discovery","url":"https://pubmed.ncbi.nlm.nih.gov/29507755","citation_count":829,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9288095","id":"PMC_9288095","title":"DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3-26.1 is deleted in malignant brain tumours.","date":"1997","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9288095","citation_count":402,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21145461","id":"PMC_21145461","title":"Dynamics of cullin-RING ubiquitin ligase network revealed by systematic quantitative proteomics.","date":"2010","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/21145461","citation_count":318,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29556344","id":"PMC_29556344","title":"Exosomal DMBT1 from human urine-derived stem cells facilitates diabetic wound repair by promoting angiogenesis.","date":"2018","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/29556344","citation_count":309,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19199708","id":"PMC_19199708","title":"Proteomic analysis of human parotid gland exosomes by multidimensional protein identification technology (MudPIT).","date":"2009","source":"Journal of proteome research","url":"https://pubmed.ncbi.nlm.nih.gov/19199708","citation_count":237,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"7784070","id":"PMC_7784070","title":"Chromosome 10 deletion mapping in human gliomas: a common deletion region in 10q25.","date":"1995","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/7784070","citation_count":191,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11007786","id":"PMC_11007786","title":"Salivary agglutinin, which binds Streptococcus mutans and Helicobacter pylori, is the lung scavenger receptor cysteine-rich protein gp-340.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11007786","citation_count":180,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10485905","id":"PMC_10485905","title":"Cloning of gp-340, a putative opsonin receptor for lung surfactant protein D.","date":"1999","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/10485905","citation_count":177,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9153228","id":"PMC_9153228","title":"Isolation and characterization of a new member of the scavenger receptor superfamily, glycoprotein-340 (gp-340), as a lung surfactant protein-D binding molecule.","date":"1997","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9153228","citation_count":177,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23602568","id":"PMC_23602568","title":"The protein interaction landscape of the human CMGC kinase group.","date":"2013","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/23602568","citation_count":174,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16740002","id":"PMC_16740002","title":"Identification of N-linked glycoproteins in human saliva by glycoprotein capture and mass spectrometry.","date":"2006","source":"Journal of proteome research","url":"https://pubmed.ncbi.nlm.nih.gov/16740002","citation_count":173,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14676191","id":"PMC_14676191","title":"Comprehensive proteomic analysis of human Par protein complexes reveals an interconnected protein network.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/14676191","citation_count":152,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16385451","id":"PMC_16385451","title":"A scan of chromosome 10 identifies a novel locus showing strong association with late-onset Alzheimer disease.","date":"2005","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16385451","citation_count":137,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17548659","id":"PMC_17548659","title":"Regulation of DMBT1 via NOD2 and TLR4 in intestinal epithelial cells modulates bacterial recognition and invasion.","date":"2007","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/17548659","citation_count":135,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20418254","id":"PMC_20418254","title":"Review: Gp-340/DMBT1 in mucosal innate immunity.","date":"2010","source":"Innate immunity","url":"https://pubmed.ncbi.nlm.nih.gov/20418254","citation_count":130,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12050164","id":"PMC_12050164","title":"Identification of the bacteria-binding peptide domain on salivary agglutinin (gp-340/DMBT1), a member of the scavenger receptor cysteine-rich superfamily.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12050164","citation_count":127,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22069308","id":"PMC_22069308","title":"A novel role for interleukin-27 (IL-27) as mediator of intestinal epithelial barrier protection mediated via differential signal transducer and activator of transcription (STAT) protein signaling and induction of antibacterial and anti-inflammatory proteins.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/22069308","citation_count":108,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15355985","id":"PMC_15355985","title":"Bacteria binding by DMBT1/SAG/gp-340 is confined to the VEVLXXXXW motif in its scavenger receptor cysteine-rich domains.","date":"2004","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15355985","citation_count":106,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15731026","id":"PMC_15731026","title":"The StcE protease contributes to intimate adherence of enterohemorrhagic Escherichia coli O157:H7 to host cells.","date":"2005","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/15731026","citation_count":103,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28986522","id":"PMC_28986522","title":"Mammalian APE1 controls miRNA processing and its interactome is linked to cancer RNA metabolism.","date":"2017","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/28986522","citation_count":99,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9888459","id":"PMC_9888459","title":"Lack of DMBT1 expression in oesophageal, gastric and colon cancers.","date":"1999","source":"British journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/9888459","citation_count":95,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10101009","id":"PMC_10101009","title":"Glycoprotein-340 binds surfactant protein-A (SP-A) and stimulates alveolar macrophage migration in an SP-A-independent manner.","date":"1999","source":"American journal of respiratory cell and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/10101009","citation_count":94,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"18020944","id":"PMC_18020944","title":"Salivary agglutinin/glycoprotein-340/DMBT1: a single molecule with variable composition and with different functions in infection, inflammation and cancer.","date":"2007","source":"Biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/18020944","citation_count":93,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"17983803","id":"PMC_17983803","title":"DMBT1 confers mucosal protection in vivo and a deletion variant is associated with Crohn's disease.","date":"2007","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/17983803","citation_count":91,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28977666","id":"PMC_28977666","title":"CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality.","date":"2017","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/28977666","citation_count":91,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":43970,"output_tokens":2273,"usd":0.083003},"stage2":{"model":"claude-opus-4-6","input_tokens":5307,"output_tokens":2348,"usd":0.127853},"total_usd":0.513278,"stage1_batch_id":"msgbatch_011rkcQdVV1RaFq9XhcG6df6","stage2_batch_id":"msgbatch_01RzgrJafdF4EWHhj5mNi6dh","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":58635,"output_tokens":5030,"usd":0.125677},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":7921,"output_tokens":3129,"usd":0.176745}},"stage1_raw":"Looking at the corpus, I need to identify what gene \"SAG\" refers to. The corpus contains two distinct proteins sharing this symbol:\n\n1. **SAG/RBX2/ROC2/RNF7** - a RING-box protein, E3 ubiquitin ligase (papers 35, 37, 65, 69, 77, 78, 81)\n2. **β-arrestins/arrestins** - the vast majority of papers (1-34, 36, 38-64, 66-68, 70-76, 79, 80, 82-100) describe arrestin family members\n\nThe gene query is \"SAG.\" Paper 65 (\"Cloning and expression of SAG: a novel marker of cellular senescence\") identifies SAG as a novel gene, and papers 35, 37, 69, 77, 78, 81 describe SAG/RBX2 as a RING-finger E3 ubiquitin ligase. The arrestin papers are about a completely different protein family. I will extract mechanistic findings only about SAG/RBX2.\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1992,\n      \"finding\": \"SAG (Sensitive to Apoptosis Gene) was cloned from human fibroblasts as a novel gene preferentially expressed in senescent cells; its expression is threefold higher in senescent fibroblasts and closely parallels the progressive slowdown in growth potential, suggesting a regulatory role in replicative senescence. DNA sequencing revealed a potential DNA-binding domain.\",\n      \"method\": \"Differential hybridization screening, DNA sequencing\",\n      \"journal\": \"Experimental cell research\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single lab, cloning/expression data with domain inference only, no functional reconstitution\",\n      \"pmids\": [\"1544376\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"SAG (also known as RBX2, ROC2, RNF7) functions as the RING component of the SCF (SKP1-CUL-F-box) E3 ubiquitin ligase complex, promoting ubiquitination and proteasomal degradation of multiple substrates including c-JUN, DEPTOR, HIF-1α, IκBα, NF1, NOXA, p27, and procaspase-3. When acting alone (without SCF partners), SAG scavenges reactive oxygen species by forming inter- and intra-molecular disulfide bonds.\",\n      \"method\": \"Biochemical characterization, ubiquitination assays, substrate accumulation upon knockdown, antioxidant activity assays\",\n      \"journal\": \"Protein & cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods across multiple substrates, replicated findings from same lab and others\",\n      \"pmids\": [\"23136067\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"SAG/RBX2 promotes lung tumorigenesis driven by KrasG12D by activating NF-κB and mTOR signaling pathways and targeting tumor suppressor substrates (p21, p27, NOXA, BIM) for ubiquitin-mediated degradation. Sag deletion in mice suppressed KrasG12D-driven lung tumor formation and extended lifespan. Growth suppression by SAG knockdown in lung cancer cells was partially rescued by simultaneous knockdown of p21 or DEPTOR (an mTOR inhibitor), placing SAG upstream of these pathways.\",\n      \"method\": \"Genetic knockout (Sag deletion in KrasG12D mice), siRNA knockdown, epistasis rescue experiments, substrate accumulation assays\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo genetic model combined with epistasis rescue and multiple orthogonal approaches\",\n      \"pmids\": [\"24430184\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"SAG RING-finger protein exhibits antioxidant activity and protects against oxidative stress and brain ischemic injury. A Tat-SAG fusion protein entered astrocytes and protected against oxidative stress-induced cell death; intraperitoneal injection in gerbils prevented neuronal cell death in the CA1 hippocampal region following transient forebrain ischemia and decreased brain lipid peroxidation. Mutant Tat-SAG lacking antioxidant activity was ineffective.\",\n      \"method\": \"Cell-free protein transduction (Tat fusion), in vivo ischemia model, immunohistochemistry, lipid peroxidation assay, mutant comparison\",\n      \"journal\": \"Free radical biology & medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vivo and in vitro experiments with mutant control, single lab\",\n      \"pmids\": [\"20100567\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"SAG-dependent ubiquitin-proteasome system (UPS) controls macrophage survival versus apoptosis during infection by ubiquitinating and degrading pro-apoptotic proteins Bax and SARM. SAG knockdown caused accumulation of Bax and SARM, leading to mitochondrial cytochrome c release and caspase-9/-3 activation. SAG-overexpressing macrophages challenged with PAMPs upregulated pro-tumorigenic cytokines (IL-1β, IL-6, TNF-α) and downregulated IL-12p40 and IL-10.\",\n      \"method\": \"siRNA knockdown, overexpression, in vitro and ex vivo macrophage assays, caspase activity, cytochrome c release, cytokine measurement\",\n      \"journal\": \"Cell death and differentiation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (knockdown, overexpression, biochemical readouts), single lab\",\n      \"pmids\": [\"24786833\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"SAG/RBX2-dependent neddylation regulates T-cell activation and proliferation. T-cell-specific SAG knockout mice showed significantly decreased T-cell activation, proliferation, and effector cytokine release in vitro and reduced graft-versus-host disease in vivo. Mechanistically, SAG-mediated effects in T cells were associated with increased suppressor of cytokine signaling (SOCS) but not NF-κB translocation.\",\n      \"method\": \"T-cell-specific genetic knockout, in vitro T-cell stimulation, allogeneic bone marrow transplantation model, cytokine assays, NF-κB/SOCS pathway analysis\",\n      \"journal\": \"The American journal of pathology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — conditional knockout with in vivo and in vitro mechanistic follow-up, single lab\",\n      \"pmids\": [\"27543965\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Gossypol inhibits cullin neddylation by directly binding to SAG-CUL5 and RBX1-CUL1 complexes. Biochemical studies showed gossypol blocked neddylation of CUL5 and CUL1 through binding to these complexes, and CUL5-H572 is a key residue for gossypol binding. This caused selective accumulation of NOXA and MCL1 (substrates of CUL5 and CUL1, respectively) in cancer cells.\",\n      \"method\": \"Alpha-Screen high-throughput screen, direct binding assays, mutagenesis (CUL5-H572), neddylation assays, substrate accumulation assays\",\n      \"journal\": \"Neoplasia\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro biochemical binding and neddylation assays with mutagenesis, single lab\",\n      \"pmids\": [\"32145688\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"SAG (also known as RBX2/ROC2/RNF7) is a RING-finger protein that functions dually: as a standalone antioxidant that scavenges reactive oxygen species via disulfide bond formation, and as the RING component of Cullin-RING E3 ubiquitin ligase (CRL) complexes that ubiquitinate and target for proteasomal degradation multiple substrates (including p21, p27, NOXA, BIM, HIF-1α, IκBα, DEPTOR, c-JUN, and procaspase-3), thereby activating NF-κB and mTOR signaling, promoting cell survival and tumorigenesis, regulating immune responses in macrophages and T cells, and functioning as a Kras-cooperating oncogene in lung tumorigenesis.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\nI'll classify each paper before extracting discoveries.\n\n**Classification:**\n\nThe gene SAG here refers to **Sensitive to Apoptosis Gene (SAG/RBX2/ROC2/RNF7)** — a RING-finger E3 ubiquitin ligase component. However, the vast majority of the retrieved corpus (papers [1]-[34] in the main corpus, plus most curated papers) concerns **β-arrestin/arrestin** proteins (ARRB1, ARRB2, SAG/S-antigen/visual arrestin). \n\nI need to distinguish:\n- **SAG as arrestin (S-antigen/visual arrestin)** — this is a different protein (rod photoreceptor arrestin, gene ARR1/SAG). This IS the canonical SAG gene (HGNC:10521, gene symbol SAG = S-antigen visual arrestin). Let me reconsider.\n\nActually, checking: The HGNC gene SAG is indeed **S-Antigen Visual Arrestin** (rod arrestin, arrestin-1). The SAG in papers [35], [37], [65], [69], [77], [78], [81] refers to \"Sensitive to Apoptosis Gene\" = RBX2, which is a **different gene** (HGNC: RNF7). That is an **alias collision**.\n\nSo KEEP: papers about visual arrestin (rod arrestin, S-antigen = SAG gene).\nEXCLUDE: Papers about β-arrestin1/2 (ARRB1/ARRB2), RBX2/SAG E3 ligase, DMBT1/SAG (salivary agglutinin), and other unrelated genes.\n\n**KEEP** (canonical SAG = visual/rod arrestin):\n- [13], [17] (cone arrestin - X-arrestin, different gene but context), [18], [20], [22], [27], [28], [33], [34], [41], [42], [43], [79], [82], [92], [95], [98]\n- Also [5] (molecular acrobatics - general arrestin mechanism including visual), [16] (polypeptide variants including arrestin), [26] (arrestin-3 — different isoform, EXCLUDE as paralog)\n\nLet me be more precise. SAG = rod photoreceptor arrestin (arrestin-1). Papers specifically about arrestin-1/visual arrestin/rod arrestin/S-antigen: [13], [18], [20], [22], [27], [28], [33], [34], [41], [42], [43], [79], [82], [92], [95], [98].\n\nPapers about β-arrestins (ARRB1/ARRB2) only: EXCLUDE.\nPapers about arrestin-3 only: EXCLUDE (paralog).\nPapers about X-arrestin/cone arrestin-4: EXCLUDE (paralog).\nRBX2/SAG E3 ligase papers: EXCLUDE (alias collision).\nDMBT1/SAG salivary agglutinin papers: EXCLUDE (alias collision).\n\n**Curated papers:** Most are about DMBT1/salivary agglutinin SAG or unrelated — EXCLUDE. None clearly about rod arrestin SAG specifically.\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1987,\n      \"finding\": \"Photoactivated rhodopsin is deactivated by a two-step mechanism: first, rhodopsin kinase phosphorylates light-activated rhodopsin at multiple sites, partially suppressing its ability to activate transducin; second, the 48 kDa S-antigen (arrestin/SAG) binds specifically to the phosphorylated, light-activated rhodopsin and potentiates the inhibitory effect, most likely by competing with transducin for binding to phosphorylated rhodopsin.\",\n      \"method\": \"Biochemical reconstitution assay measuring transducin-mediated phosphodiesterase activation in rod outer segment preparations; competitive binding experiments\",\n      \"journal\": \"Journal of receptor research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted in vitro with purified components; foundational mechanism paper replicated across labs\",\n      \"pmids\": [\"3040978\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1989,\n      \"finding\": \"Arrestin (SAG) specifically inhibits the dephosphorylation of freshly photolyzed (light-activated) phosphorhodopsin by protein phosphatase 2A (PP2A), but does not inhibit dephosphorylation of unbleached rhodopsin nor dephosphorylation of phosphorylase a, indicating substrate-directed protection. This reveals a novel regulatory mechanism by which arrestin binding prevents PP2A access to phosphorhodopsin.\",\n      \"method\": \"In vitro phosphatase activity assay with purified rod outer segment extracts, okadaic acid inhibition, DEAE-Sepharose chromatography co-elution of opsin phosphatase with PP2A\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro enzymatic assay with rigorous substrate specificity controls; multiple orthogonal biochemical methods\",\n      \"pmids\": [\"2550422\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1992,\n      \"finding\": \"Reduction of the photolyzed chromophore all-trans-retinal to all-trans-retinol is essential for recycling of photoactivated rhodopsin: once reduction occurs, arrestin dissociates from the receptor and the chromophore site becomes accessible for regeneration. When reduction does not occur, free all-trans-retinal can form a Meta II-like pseudo-photoproduct (M380) that binds arrestin tightly and blocks rhodopsin regeneration.\",\n      \"method\": \"Spectrophotometric analysis of rhodopsin photoproducts; binding assays of arrestin and rhodopsin kinase to M380 vs native metarhodopsin species; biochemical manipulation of retinal reduction in rod outer segment preparations\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with purified components; multiple functional readouts; mechanistic causality established\",\n      \"pmids\": [\"1386362\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"The transition of arrestin from its inactive (basal) conformation to the high-affinity receptor-binding state is triggered by the phosphorylated C-terminal tail of rhodopsin disrupting a hydrogen-bonded network of buried charged residues called the 'polar core' (involving Arg175, Asp30, Asp296, Asp303, Arg382). Mutations that disrupt polar core interactions (e.g., R175E, D296R) bypass the requirement for receptor phosphorylation, enabling arrestin to bind activated, unphosphorylated rhodopsin.\",\n      \"method\": \"Site-directed mutagenesis of arrestin residues; in vitro binding assays to light-activated phosphorylated and unphosphorylated rhodopsin; second-site suppressor mutagenesis restoring critical interactions; interpreted in conjunction with crystal structure\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — mutagenesis + in vitro functional assay + structural validation; structure-based second-site suppressor mutations confirm the mechanism\",\n      \"pmids\": [\"10206946\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"The principal region of arrestin that mediates binding to photoactivated phosphorhodopsin is contained within residues 90–140, with the minimal inhibitory peptide mapping to residues 109–130 (IC50 ~1.1 mM). A GST fusion of residues 95–140 binds rhodopsin regardless of activation or phosphorylation state, indicating this is a primary contact region.\",\n      \"method\": \"Phage display of arrestin fragments panned against phosphorylated rhodopsin; synthetic peptide competition assay measuring inhibition of arrestin binding and cGMP phosphodiesterase activation; GST fusion protein pulldown\",\n      \"journal\": \"Biochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (phage display, peptide competition, fusion protein pulldown); single lab\",\n      \"pmids\": [\"10052946\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Peptide competition assays identified two regions of arrestin (residues 11–30 and 51–70 in the N-terminal domain; residues 231–260 in the C-terminal domain) that interact with metarhodopsin II (MII), with arrestin peptide 11–30 showing selectivity for phosphorylated MII over the transducin-stabilized form. Both the N- and C-terminal domains of arrestin contact rhodopsin, and these sites overlap with transducin-binding surfaces.\",\n      \"method\": \"Spectrophotometric extra-MII stabilization assay; synthetic peptide competition of arrestin- and transducin-dependent MII stabilization using native disc membranes\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean in vitro competition assay with functional readout; single lab but well-controlled\",\n      \"pmids\": [\"10969086\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Arrestin release from rhodopsin and retinal (chromophore) release are directly linked events with similar activation energies. Arrestin slows the rate of retinal release approximately 2-fold at physiological temperatures and abolishes the pH dependence of retinal release. Fluorescence labeling at I72C and S251C reveals these sites are buried at the rhodopsin-arrestin or phospholipid-arrestin interface upon binding. Evidence also indicates arrestin can bind a post-Meta II photodecay product (possibly Meta III).\",\n      \"method\": \"Fluorescence spectroscopy using monobromobimane-labeled arrestin mutants; kinetic analysis of arrestin and retinal release; EPR and biochemical approaches\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple orthogonal methods (fluorescence, EPR, biochemical); defines mechanistic linkage between arrestin and retinal release with activation energy measurements\",\n      \"pmids\": [\"15591052\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Arrestin-1 mutants with enhanced ability to bind active, unphosphorylated rhodopsin (bypassing the need for rhodopsin kinase phosphorylation) partially compensate for defects in rhodopsin phosphorylation in rod photoreceptors in vivo, promoting photoreceptor survival, improving functional ERG responses, and facilitating photoresponse recovery in rhodopsin kinase-deficient mice.\",\n      \"method\": \"Transgenic mouse model expressing enhanced arrestin-1 mutant in rhodopsin kinase (RK)-deficient rods; electroretinography; photoreceptor cell counting; functional photoresponse recovery measurements\",\n      \"journal\": \"Current biology : CB\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo genetic rescue experiment with functional and morphological readouts; demonstrates sufficiency of enhanced arrestin-1 for single-step receptor deactivation\",\n      \"pmids\": [\"19361994\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Arrestin-1 (SAG) is essential for cone photoreceptor survival and light adaptation. In Arr1-knockout mice reared in darkness, viable cone density diminishes over time, and cone ERG b-wave amplitudes fail to increase during light adaptation (3–15 min background illumination), a defect rescued by restoration of Arr1 expression. Either Arr1 or Arr4 is sufficient to maintain normal cone flicker responses.\",\n      \"method\": \"Arrestin-1 and arrestin-4 knockout mice; quantitative retinal morphology; TUNEL apoptosis assay; immunohistochemistry; electroretinography (ERG) light adaptation and flicker protocols; transgenic rescue\",\n      \"journal\": \"Investigative ophthalmology & visual science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple knockout genotypes with functional ERG and morphological readouts; transgenic rescue confirms specificity\",\n      \"pmids\": [\"20019357\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Upon binding to light-activated phosphorylated rhodopsin (P-Rh*), the 'finger loop' (residues 67–79) of arrestin-1 moves toward the expected location of P-Rh*, but does not adopt a fully extended conformation. A striking movement of the loop containing residue 139 away from the adjacent finger loop facilitates receptor binding. The relative position of the N and C domains remains largely unchanged (contra the 'clam-shell' model). Loops at residues 139, 157, and 344 show high flexibility in both free and receptor-bound arrestin-1.\",\n      \"method\": \"Double electron-electron resonance (DEER) EPR spectroscopy with spin-labeled arrestin-1 pairs; distance measurements in free vs. P-Rh*-bound arrestin-1\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — DEER/EPR distance measurements provide direct structural information on receptor-bound conformation; multiple spin-label pairs\",\n      \"pmids\": [\"23091036\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"The crystal structure of bovine arrestin-1 splice variant p44 (C-tail truncation mimicking activation) at 3.0 Å reveals the pre-activated arrestin conformation: breakage of the polar core and other interlobe hydrogen-bond networks leads to ~21° rotation of the two lobes. Key receptor-binding loops in the central crest region (finger loop, loop 139, gate loop Asp296–Asn305) rearrange from restricted to extended conformations. C-tail displacement releases these loops and enables receptor binding, confirmed by site-directed fluorescence spectroscopy.\",\n      \"method\": \"X-ray crystallography at 3.0 Å; site-directed fluorescence spectroscopy validating conformational changes; comparison with basal arrestin-1 structure\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure plus functional fluorescence validation; high-impact journal; provides structural mechanism of activation\",\n      \"pmids\": [\"23604253\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Scanning mutagenesis of all arrestin-1 residues reveals that binding to phosphorylated agonist-bound rhodopsin (Meta II-P) and phosphorylated apo-receptor (Ops-P) both require arrestin activation (polar core disruption or C-tail displacement), but the two complexes are structurally distinct: phosphate-binding residues (phosphosensors), inter-domain interface residues, receptor-binding loops, and C-edge residues contribute differently to the two receptor forms, indicating different binding modes.\",\n      \"method\": \"Unbiased scanning mutagenesis of all arrestin residues; in vitro binding assays to Meta II-P and Ops-P; quantitative comparison of mutant effects across both receptor forms\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — comprehensive mutagenesis across entire protein with two distinct receptor state readouts; systematic and well-controlled\",\n      \"pmids\": [\"27350090\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Molecular dynamics simulations and site-directed fluorescence spectroscopy demonstrate that C-edge loops of arrestin-1 function as a membrane anchor during rhodopsin interaction. Activation of arrestin by receptor-attached phosphates is necessary for C-edge engagement of the membrane. The C-edge conformation and orientation differ between the pre-complex (arrestin interacting with phosphorylated receptor C-terminus only) and the high-affinity complex.\",\n      \"method\": \"Molecular dynamics simulations; site-directed fluorescence spectroscopy experiments on arrestin-1 interactions with rhodopsin in membranes\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — MD simulations validated by site-directed fluorescence spectroscopy; mechanistically defines membrane anchoring role of C-edge\",\n      \"pmids\": [\"28220785\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Comprehensive mutagenesis of the finger loop in bovine visual arrestin-1 demonstrates that the finger loop is the key element of the activation sensor: the majority of finger loop residues are important for binding to light-activated rhodopsin, with six mutations affecting binding exclusively to the light-activated form (not phosphorylated dark rhodopsin or unphosphorylated active rhodopsin). This establishes the finger loop as the structural element that detects the active conformation of the receptor.\",\n      \"method\": \"Comprehensive site-directed mutagenesis of finger loop residues in arrestin-1; cell-free translation of radiolabeled mutant proteins; in vitro binding assays to multiple rhodopsin functional forms (P-Rh*, Rh*, P-Rh, Rh); tested in both WT and C-terminally truncated arrestin-1 backgrounds\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — comprehensive mutagenesis across full finger loop with multiple receptor state readouts; systematic and internally controlled\",\n      \"pmids\": [\"33159335\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Inositol phosphates (InsPs) bind to the N-domain basic patch of visual arrestin-1 (Arr1), displacing the C-tail, suggesting they prime Arr1 for rhodopsin interaction and may direct Arr1 translocation from inner to outer photoreceptor segments. Crystal structures show that C-tail removal by InsP binding leaves the polar core intact, indicating InsP binding is insufficient to fully activate Arr1 but acts as a priming step.\",\n      \"method\": \"X-ray crystallography of bovine Arr1 in ligand-free state (near-complete C-tail model) and InsP-bound states; structural comparison\",\n      \"journal\": \"Structure (London, England : 1993)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — crystal structure with near-complete C-tail model; mechanistic interpretation of InsP binding and priming supported by structural data\",\n      \"pmids\": [\"34678158\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"SAG (visual/rod arrestin, arrestin-1) terminates phototransduction by binding specifically to light-activated, rhodopsin kinase-phosphorylated rhodopsin: phosphorylated receptor C-tail contacts the arrestin N-domain basic patch and phosphosensors, disrupting a buried polar core (Arg175, Asp30, Asp296, Asp303, Arg382) and releasing the C-tail, which triggers an ~21° inter-domain rotation, extension of the finger loop and loop-139 into the receptor cavity, and engagement of C-edge loops as a membrane anchor; once bound, arrestin sterically blocks transducin coupling, inhibits PP2A-mediated dephosphorylation of phosphorhodopsin, slows retinal chromophore release (linking arrestin dissociation to retinal reduction), and is essential in vivo for cone photoreceptor survival and light adaptation, while inositol phosphates can prime arrestin for receptor binding by displacing its C-tail without fully activating it.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"SAG (also known as RBX2/ROC2/RNF7) is a RING-finger protein that serves as the RING component of SCF-type Cullin-RING E3 ubiquitin ligase (CRL) complexes and, independently, functions as a direct antioxidant. Within CRL complexes, SAG promotes ubiquitination and proteasomal degradation of multiple substrates—including p21, p27, NOXA, BIM, DEPTOR, HIF-1α, IκBα, c-JUN, procaspase-3, Bax, and SARM—thereby activating NF-κB and mTOR signaling, suppressing apoptosis, and promoting cell survival and tumorigenesis [PMID:23136067, PMID:24430184, PMID:24786833]. As a standalone protein, SAG scavenges reactive oxygen species through inter- and intra-molecular disulfide bond formation, conferring cytoprotection against oxidative stress and ischemic injury [PMID:23136067, PMID:20100567]. SAG is required for Kras-driven lung tumorigenesis in vivo and regulates immune cell function, including macrophage survival and cytokine production as well as T-cell activation and proliferation via neddylation-dependent control of SOCS levels [PMID:24430184, PMID:24786833, PMID:27543965].\",\n  \"teleology\": [\n    {\n      \"year\": 1992,\n      \"claim\": \"Initial cloning of SAG revealed it as a novel gene enriched in senescent fibroblasts, raising the question of whether it regulates replicative growth arrest.\",\n      \"evidence\": \"Differential hybridization screening of senescent versus young human fibroblasts with DNA sequencing\",\n      \"pmids\": [\"1544376\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No functional assay performed; role inferred solely from expression pattern\",\n        \"Predicted DNA-binding domain not validated\",\n        \"No link to ubiquitin-proteasome system or antioxidant function established\"\n      ]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Demonstration that SAG's RING-finger domain directly confers antioxidant activity in vivo established a cytoprotective function independent of its E3 ligase role.\",\n      \"evidence\": \"Tat-SAG protein transduction into astrocytes and intraperitoneal injection in gerbil forebrain ischemia model, with antioxidant-dead mutant as control\",\n      \"pmids\": [\"20100567\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Mechanism of ROS scavenging (which disulfide bonds, redox cycling) not structurally resolved\",\n        \"Relative contribution of antioxidant versus E3 ligase activity to neuroprotection not dissected\"\n      ]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Comprehensive biochemical characterization unified SAG's dual functions: as the RING component of SCF E3 ligases targeting multiple substrates for degradation, and as a standalone ROS scavenger via disulfide bond formation.\",\n      \"evidence\": \"Ubiquitination assays, substrate accumulation upon knockdown, and antioxidant activity assays across multiple substrates\",\n      \"pmids\": [\"23136067\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Structural basis for substrate selectivity among different CRL complexes not determined\",\n        \"Relative physiological importance of SCF-dependent versus antioxidant functions unclear\"\n      ]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Genetic deletion of Sag in KrasG12D mice proved SAG is required for Kras-driven lung tumorigenesis, functioning upstream of NF-κB and mTOR by degrading tumor suppressors p21, p27, NOXA, BIM, and the mTOR inhibitor DEPTOR.\",\n      \"evidence\": \"Conditional Sag knockout in KrasG12D lung tumor model, epistasis rescue by co-knockdown of p21 or DEPTOR, substrate accumulation assays\",\n      \"pmids\": [\"24430184\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether SAG is required for tumor maintenance (not just initiation) untested\",\n        \"Specific F-box proteins partnering SAG in lung epithelium not identified\"\n      ]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"SAG was shown to govern macrophage survival during infection by ubiquitinating pro-apoptotic Bax and SARM, linking CRL-mediated degradation to innate immune regulation and pro-tumorigenic cytokine skewing.\",\n      \"evidence\": \"siRNA knockdown and overexpression in macrophages, cytochrome c release, caspase activation, and cytokine profiling upon PAMP challenge\",\n      \"pmids\": [\"24786833\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Direct ubiquitination of Bax and SARM by SAG-containing CRL not reconstituted in vitro\",\n        \"In vivo relevance of macrophage SAG in tumor microenvironment not tested\"\n      ]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"T-cell-specific SAG deletion revealed that SAG-dependent neddylation is essential for T-cell activation and proliferation, operating through SOCS accumulation rather than NF-κB, expanding SAG's role to adaptive immunity.\",\n      \"evidence\": \"Conditional T-cell knockout, in vitro stimulation assays, allogeneic bone marrow transplant graft-versus-host disease model, NF-κB and SOCS pathway analysis\",\n      \"pmids\": [\"27543965\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Identity of SAG-CRL substrate(s) controlling SOCS levels in T cells unknown\",\n        \"Whether SAG deletion affects specific T-cell subsets differentially not addressed\"\n      ]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Identification of gossypol as a direct inhibitor of SAG-CUL5 and RBX1-CUL1 neddylation provided chemical tool evidence that SAG-dependent CRL activation is druggable, with substrate-selective effects on NOXA and MCL1.\",\n      \"evidence\": \"AlphaScreen high-throughput screen, direct binding assays, CUL5-H572 mutagenesis, neddylation and substrate accumulation assays\",\n      \"pmids\": [\"32145688\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Selectivity of gossypol for SAG-CUL5 over RBX1-CUL1 in cells not fully resolved\",\n        \"In vivo anti-tumor efficacy via SAG-specific inhibition not demonstrated\",\n        \"Binding mode at atomic resolution not determined\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the structural basis for SAG's substrate selectivity across different CRL assemblies, the relative physiological contributions of its E3 ligase versus antioxidant activities in specific tissues, and whether SAG is a viable therapeutic target for established tumors.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No high-resolution structure of SAG in complex with a cullin and substrate receptor\",\n        \"Separation-of-function mutations distinguishing E3 ligase from antioxidant roles not generated in vivo\",\n        \"Tumor maintenance (versus initiation) role of SAG not tested in conditional deletion models\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": [1, 2, 4, 5, 6]},\n      {\"term_id\": \"GO:0016209\", \"supporting_discovery_ids\": [1, 3]},\n      {\"term_id\": \"GO:0016874\", \"supporting_discovery_ids\": [1, 2]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [1, 2]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0140096\", \"supporting_discovery_ids\": []},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [1, 2, 4]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [2, 5]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [4, 5]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [2, 4]}\n    ],\n    \"complexes\": [\n      \"SCF (SKP1-CUL-F-box) E3 ubiquitin ligase\",\n      \"SAG-CUL5 CRL complex\"\n    ],\n    \"partners\": [\n      \"CUL1\",\n      \"CUL5\",\n      \"SKP1\",\n      \"NOXA\",\n      \"DEPTOR\",\n      \"BAX\",\n      \"SARM1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"SAG (S-arrestin/arrestin-1) is the principal terminator of rod phototransduction, binding light-activated, rhodopsin kinase–phosphorylated rhodopsin to sterically block transducin coupling and shield the receptor from PP2A-mediated dephosphorylation [PMID:3040978, PMID:2550422]. Phosphorylated rhodopsin's C-tail disrupts arrestin's buried polar core (Arg175–Asp30–Asp296–Asp303–Arg382), releasing the autoinhibitory C-tail and triggering an ~21° inter-domain rotation that extends the finger loop and loop-139 into the receptor cavity while C-edge loops anchor to the membrane [PMID:10206946, PMID:23604253, PMID:28220785, PMID:33159335]. Arrestin binding slows retinal chromophore release from rhodopsin, coupling arrestin dissociation to all-trans-retinal reduction and visual-cycle recycling [PMID:1386362, PMID:15591052]. In vivo, SAG is essential for cone photoreceptor survival and light adaptation, and enhanced-binding arrestin-1 mutants can partially rescue rhodopsin kinase deficiency [PMID:20019357, PMID:19361994].\",\n  \"teleology\": [\n    {\n      \"year\": 1987,\n      \"claim\": \"Established that rhodopsin shut-off requires two sequential steps — phosphorylation by rhodopsin kinase followed by SAG binding — resolving how transducin activation is quenched after photon absorption.\",\n      \"evidence\": \"Biochemical reconstitution measuring transducin-stimulated PDE activity in rod outer segments with purified components\",\n      \"pmids\": [\"3040978\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Stoichiometry of phosphorylation sites required for arrestin binding was undefined\", \"Mechanism of arrestin selectivity for phosphorylated vs. unphosphorylated receptor was unknown\"]\n    },\n    {\n      \"year\": 1989,\n      \"claim\": \"Revealed a second regulatory function of arrestin — shielding phosphorhodopsin from PP2A-mediated dephosphorylation — explaining how the deactivated state is maintained until the receptor is recycled.\",\n      \"evidence\": \"In vitro phosphatase assays with purified rod outer segment extracts and substrate specificity controls\",\n      \"pmids\": [\"2550422\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the in vivo opsin phosphatase was not settled\", \"Whether arrestin shielding is relieved by retinal release was untested\"]\n    },\n    {\n      \"year\": 1992,\n      \"claim\": \"Linked arrestin dissociation from rhodopsin to all-trans-retinal reduction, establishing that visual-cycle chromophore recycling cannot proceed while arrestin remains bound.\",\n      \"evidence\": \"Spectrophotometric analysis of rhodopsin photoproducts and arrestin binding to M380 pseudo-photoproduct\",\n      \"pmids\": [\"1386362\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Kinetic coupling between retinal reduction and arrestin release was not quantified at physiological temperature\", \"Enzyme identity for retinal reduction in situ was not addressed\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Identified the polar core (Arg175, Asp30, Asp296, Asp303, Arg382) as the phosphosensor whose disruption switches arrestin from the basal to the receptor-binding conformation, answering how arrestin discriminates phosphorylated from unphosphorylated receptor.\",\n      \"evidence\": \"Site-directed and second-site suppressor mutagenesis with in vitro rhodopsin binding assays, interpreted alongside the crystal structure\",\n      \"pmids\": [\"10206946\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full structural view of the activated state was lacking\", \"Which phosphorylation sites on rhodopsin contact the polar core was unresolved\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Mapped the primary rhodopsin-contact surface of arrestin to residues 90–140, narrowing the receptor-binding interface and highlighting the finger-loop region.\",\n      \"evidence\": \"Phage display, synthetic peptide competition of arrestin binding, and GST-fusion pulldowns\",\n      \"pmids\": [\"10052946\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Peptide-based mapping cannot capture conformational contributions\", \"Residue-level resolution within the 90–140 segment was not achieved\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Quantified that arrestin slows retinal release ~2-fold and that arrestin and retinal dissociation share similar activation energies, mechanistically coupling receptor desensitization to chromophore recycling kinetics.\",\n      \"evidence\": \"Fluorescence spectroscopy with monobromobimane-labeled arrestin mutants; kinetic and thermodynamic analysis\",\n      \"pmids\": [\"15591052\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether the coupling is direct or mediated by conformational intermediates was unresolved\", \"In vivo relevance of the ~2-fold slowing was not tested\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Demonstrated in vivo that SAG is essential for cone survival and light adaptation, and that enhanced-binding arrestin-1 mutants can partly rescue rhodopsin kinase deficiency, establishing the physiological sufficiency of arrestin for single-step receptor shut-off.\",\n      \"evidence\": \"Arrestin-1 and arrestin-4 knockout mice; transgenic rescue; ERG light-adaptation and flicker protocols; photoreceptor morphometry\",\n      \"pmids\": [\"20019357\", \"19361994\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which SAG promotes cone survival independent of rod desensitization was unclear\", \"Whether enhanced mutants cause long-term toxicity in vivo was not assessed\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"DEER/EPR distance measurements on receptor-bound arrestin-1 showed that the finger loop and loop-139 move toward the receptor upon binding but the inter-domain arrangement is more subtle than a simple clam-shell opening, revising the structural model of arrestin activation.\",\n      \"evidence\": \"Double electron-electron resonance (DEER) EPR with multiple spin-label pairs on arrestin-1 free and bound to P-Rh*\",\n      \"pmids\": [\"23091036\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Full atomic-resolution model of the rhodopsin–arrestin complex was still missing\", \"Contribution of membrane lipids to the bound-state conformation was not addressed\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Crystal structure of the pre-activated arrestin-1 (p44 splice variant) at 3.0 Å revealed the ~21° inter-domain rotation, polar-core breakage, and central-crest loop rearrangements triggered by C-tail displacement, providing the first high-resolution view of the activated arrestin conformation.\",\n      \"evidence\": \"X-ray crystallography of arrestin-1 p44; site-directed fluorescence spectroscopy validation\",\n      \"pmids\": [\"23604253\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structure was of a C-tail-truncated variant, not of the full-length receptor-bound complex\", \"Dynamics of the transition from basal to activated state were not captured\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Comprehensive scanning mutagenesis showed that arrestin-1 engages phosphorylated agonist-bound (Meta II-P) and phosphorylated apo-receptor (Ops-P) rhodopsin through structurally distinct binding modes, with different contributions of phosphosensors, inter-domain interface, and C-edge loops.\",\n      \"evidence\": \"Systematic mutagenesis of all arrestin residues; quantitative in vitro binding to Meta II-P vs. Ops-P\",\n      \"pmids\": [\"27350090\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of the distinct binding modes at atomic resolution was not available\", \"Physiological significance of the Ops-P complex in dark adaptation was unclear\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Identified C-edge loops as a phosphorylation-dependent membrane anchor that adopts different orientations in the pre-complex versus the high-affinity complex, adding a lipid-engagement step to the arrestin activation model.\",\n      \"evidence\": \"Molecular dynamics simulations validated by site-directed fluorescence spectroscopy of arrestin-1 on rhodopsin-containing membranes\",\n      \"pmids\": [\"28220785\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Lipid specificity of C-edge engagement was not defined\", \"Whether C-edge membrane anchoring is required in vivo was untested\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Comprehensive finger-loop mutagenesis established this element as the primary activation sensor of arrestin-1, with six residues selectively required for binding only to the light-activated receptor form, separating the activation-sensing and phosphosensing functions of arrestin.\",\n      \"evidence\": \"Site-directed mutagenesis of all finger-loop residues; binding assays to four distinct rhodopsin functional forms in WT and C-tail-truncated backgrounds\",\n      \"pmids\": [\"33159335\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether these residues insert into the receptor transmembrane core was structurally unconfirmed for visual arrestin\", \"Energetic contribution of individual finger-loop contacts was not measured\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Crystal structures of arrestin-1 with inositol phosphates showed that InsPs displace the C-tail by binding the N-domain basic patch but leave the polar core intact, defining a priming mechanism distinct from full activation and potentially regulating arrestin translocation in photoreceptors.\",\n      \"evidence\": \"X-ray crystallography of bovine Arr1 ligand-free (with near-complete C-tail) and InsP-bound states\",\n      \"pmids\": [\"34678158\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo role of InsP-mediated priming in arrestin translocation is undemonstrated\", \"Whether InsP priming synergizes with partial receptor phosphorylation was untested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"A high-resolution structure of full-length mammalian arrestin-1 bound to native phosphorylated rhodopsin in a lipid bilayer, capturing the complete binding interface including C-edge membrane contacts, remains to be determined.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No cryo-EM or crystal structure of the full-length mammalian Arr1–P-Rh* complex in a membrane environment\", \"Kinetic pathway of arrestin activation (order of polar-core disruption, C-tail release, finger-loop insertion, membrane anchoring) is not resolved in real time\", \"In vivo role of InsP-mediated priming in photoreceptor arrestin translocation lacks direct evidence\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 1, 7, 8]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [0, 3, 11]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [12]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [14]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0009709\", \"supporting_discovery_ids\": [0, 2, 6, 7, 8]},\n      {\"term_id\": \"R-HSA-9709957\", \"supporting_discovery_ids\": [0, 2, 7, 8]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 3, 7, 8]}\n    ],\n    \"complexes\": [\n      \"Rhodopsin–arrestin-1 complex\"\n    ],\n    \"partners\": [\n      \"RHO\",\n      \"GRK1\",\n      \"PPP2CA\",\n      \"SAG\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}